col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


45 Ergebisse       Seite 1

 [1] 
Springer (Biomed Central Ltd.): Immunity & Ageing
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mrz―12 Delayed viral clearance and altered inflammatory responses affect severity of SARS-CoV-2 infection in aged mice Émile Lacasse, Isabelle Dubuc, Leslie Gudimard, Ana Claudia dos S. P. Andrade, Annie Gravel, Karine Greffard, et al. (+8)
2 [GO] 2025―Jan―02 High SARS-CoV-2 antibody levels after three consecutive BNT162b2 booster vaccine doses in nursing home residents Marloes I Hofstee, Joanna Kaczorowska, Abigail Postema, Erna Zomer, Maren van Waalwijk, Gustaaf Jonathans, et al. (+5)
3 [GO] 2024―Okt―15 Health characteristics associated with persistence of SARS-CoV-2 antibody responses after repeated vaccinations in older persons over time: the Doetinchem cohort study Yunus Kuijpers, Joanna Kaczorowska, H. Susan J. Picavet, Mary-lène de Zeeuw-Brouwer, Marjan Kuijer, Irene Slits, et al. (+5)
4 [GO] 2024―Sep―13 Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adults Anne T. Gelderloos, Marije K. Verheul, Irene Middelhof, Mary-Lène de Zeeuw-Brouwer, Robert S. van Binnendijk, Anne-Marie Buisman, Puck B. van Kasteren
5 [GO] 2024―Jul―30 Overcoming the age-dependent SARS-CoV-2 vaccine response through hybrid immunity: analysis of humoral and cellular immunity with mass cytometry profiling Zayakhuu Gerelkhuu, Sehee Park, Kyoung Hwa Lee, Yong Chan Kim, Sook Jin Kwon, Kyoung-Ho Song, et al. (+16)
6 [GO] 2024―Jun―27 Centenarians, semi and supercentenarians, COVID-19 and Spanish flu: a serological assessment to gain insight into the resilience of older centenarians to COVID-19 Claudia Maria Trombetta, Giulia Accardi, Anna Aiello, Anna Calabrò, Calogero Caruso, Mattia Emanuela Ligotti, et al. (+5)
7 [GO] 2024―Jun―22 Kinetics of pro- and anti-inflammatory spike-specific cellular immune responses in long-term care facility residents after COVID-19 mRNA primary and booster vaccination: a prospective longitudinal study in Japan Tomoyuki Kakugawa, Yusuke Mimura, Yuka Mimura-Kimura, Keiko Doi, Yuichi Ohteru, Hiroyuki Kakugawa, et al. (+4)
8 [GO] 2024―Mai―07 Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people Johanne Poisson, Carine El-Sissy, Arnaud Serret-Larmande, Nikaïa Smith, Morgane Lebraud, Jean-Loup Augy, et al. (+26)
9 [GO] 2024―Mrz―21 Changes in the innate immune response to SARS-CoV-2 with advancing age in humans Sudhanshu Agrawal, Michelle Thu Tran, Tara Sinta Kartika Jennings, Marlaine Maged Hosny Soliman, Sally Heo, Bobby Sasson, et al. (+2)
10 [GO] 2024―Mrz―08 Excess of body weight is associated with accelerated T-cell senescence in hospitalized COVID-19 patients Mailton Prestes Madruga, Lucas Kich Grun, Letícya Simone Melo Dos Santos, Frederico Orlando Friedrich, Douglas Bitencourt Antunes, Marcella Elesbão Fogaça Rocha, et al. (+13)
11 [GO] 2024―Jan―27 Antibody and transcription landscape in peripheral blood mononuclear cells of elderly adults over 70 years of age with third dose of COVID-19 BBIBP-CorV and ZF2001 booster vaccine Yuwei Zhang, Lianxiang Zhao, Jinzhong Zhang, Xiaomei Zhang, Shanshan Han, Qingshuai Sun, et al. (+4)
12 [GO] 2024―Jan―11 Accelarated immune ageing is associated with COVID-19 disease severity Janet M. Lord, Tonny Veenith, Jack Sullivan, Archana Sharma-Oates, Alex G. Richter, Neil J. Greening, et al. (+1017)
13 [GO] 2023―Dez―18 Blood circulating bacterial DNA in hospitalized old COVID-19 patients Robertina Giacconi, Patrizia D’Aquila, Maurizio Cardelli, Francesco Piacenza, Elisa Pierpaoli, Giada Sena, et al. (+13)
14 [GO] 2023―Okt―25 Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study Yunus Kuijpers, H. Susan J. Picavet, Lia de Rond, Mary-lène de Zeeuw-Brouwer, Ryanne Rutkens, Esther Gijsbers, et al. (+4)
15 [GO] 2023―Aug―17 Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents: a prospective longitudinal study in Japan Tomoyuki Kakugawa, Keiko Doi, Yuichi Ohteru, Hiroyuki Kakugawa, Keiji Oishi, Masahiro Kakugawa, et al. (+3)
16 [GO] 2023―Jul―05 The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2 M. S. Espinar-Buitrago, L. Tarancon-Diez, E. Vazquez-Alejo, E. Magro-Lopez, M. Genebat, F. Romero-Candau, et al. (+2)
17 [GO] 2023―Apr―12 Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions Ludmila Müller, Svetlana Di Benedetto
18 [GO] 2023―Mrz―06 Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home María del Mar Pozo-Balado, Ángel Bulnes-Ramos, Israel Olivas-Martínez, Vanesa Garrido-Rodríguez, Carmen Lozano, Ana I. Álvarez-Ríos, et al. (+9)
19 [GO] 2023―Jan―17 Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults Charles T. Semelka, Michael E. DeWitt, Maria W. Blevins, Beth C. Holbrook, John W. Sanders, Martha A. Alexander-Miller
20 [GO] 2022―Dez―15 Biomarkers of cell damage, neutrophil and macrophage activation associated with in-hospital mortality in geriatric COVID-19 patients M. Cardelli, E. Pierpaoli, F. Marchegiani, F. Marcheselli, F. Piacenza, R. Giacconi, et al. (+17)
21 [GO] 2022―Dez―07 Correction: The oldest unvaccinated Covid-19 survivors in South America Mateus V. de Castro, Monize V. R. Silva, Michel S. Naslavsky, Marilia O. Scliar, Kelly Nunes, Maria Rita Passos-Bueno, et al. (+19)
22 [GO] 2022―Nov―16 The oldest unvaccinated Covid-19 survivors in South America Mateus V. de Castro, Monize V. R. Silva, Michel S. Naslavsky, Marilia O. Scliar, Kelly Nunes, Maria Rita Passos-Bueno, et al. (+19)
23 [GO] 2022―Nov―11 Aging, inflammaging and immunosenescence as risk factors of severe COVID-19 Anteneh Mehari Tizazu, Hylemariam Mihiretie Mengist, Gebreselassie Demeke
24 [GO] 2022―Aug―22 Shorter telomere length is associated with COVID-19 hospitalization and with persistence of radiographic lung abnormalities Miriam Retuerto, Ana Lledó, Beatriz Fernandez-Varas, Rosa Guerrero-López, Alicia Usategui, Antonio Lalueza, et al. (+6)
25 [GO] 2022―Jul―14 Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity Bart N. Ford, Jonathan Savitz
26 [GO] 2022―Mai―24 Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine Chalerm Liwsrisakun, Supansa Pata, Witida Laopajon, Nuchjira Takheaw, Warawut Chaiwong, Juthamas Inchai, et al. (+10)
27 [GO] 2022―Mrz―05 Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19 Xixi Jing, Min Xu, Deye Song, Tingting Yue, Yali Wang, Pan Zhang, et al. (+6)
28 [GO] 2022―Jan―22 What’s happening where when SARS-CoV-2 infects: are TLR7 and MAFB sufficient to explain patient vulnerability? Ludwig Englmeier, Julien Subburayalu
29 [GO] 2021―Okt―30 SARS-CoV-2 and EBV; the cost of a second mitochondrial “whammy”? Alistair V.W. Nunn, Geoffrey W. Guy, Stanley W. Botchway, Jimmy D. Bell
30 [GO] 2021―Okt―10 Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond Birgit Weinberger
31 [GO] 2021―Sep―22 Validation of the effectiveness of SARS-CoV-2 vaccines in older adults in “real-world” settings Nan-ping Weng, Graham Pawelec
32 [GO] 2021―Jun―01 A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases Yuanyuan Wang, Shu-Chao Pang, Ying Yang
33 [GO] 2021―Mai―20 The age again in the eye of the COVID-19 storm: evidence-based decision making María C. Martín, Aurora Jurado, Cristina Abad-Molina, Antonio Orduña, Oscar Yarce, Ana M. Navas, et al. (+42)
34 [GO] 2021―Mrz―30 Hypothetical COVID-19 protection mechanism: hints from centenarians Franca Rosa Guerini, Matteo Cesari, Beatrice Arosio
35 [GO] 2021―Mrz―12 Does reactivation of cytomegalovirus contribute to severe COVID-19 disease? Cecilia Söderberg-Nauclér
36 [GO] 2021―Feb―20 Unanticipated efficacy of SARS-CoV-2 vaccination in older adults Graham Pawelec, Janet McElhaney
37 [GO] 2021―Jan―04 Obesity and COVID-19: what makes obese host so vulnerable? Sameer Mohammad, Rafia Aziz, Saeed Al Mahri, Shuja Shafi Malik, Esraa Haji, Altaf Husain Khan, et al. (+2)
38 [GO] 2020―Nov―14 An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, Julio Betancourt, Carlos Herrera, et al. (+11)
39 [GO] 2020―Nov―09 SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing Alistair V. W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, Stanley W. Botchway, Wayne Frasch, Edward J. Calabrese, Jimmy D. Bell
40 [GO] 2020―Aug―24 A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Arsun Bektas, Shepherd H. Schurman, Claudio Franceschi, Luigi Ferrucci
41 [GO] 2020―Aug―14 COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study Aurora Jurado, María C. Martín, Cristina Abad-Molina, Antonio Orduña, Alba Martínez, Esther Ocaña, et al. (+31)
42 [GO] 2020―Jun―30 SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done? Caio Henrique Mazucanti, Josephine Mary Egan
43 [GO] 2020―Mai―27 “The ancient and the new”: is there an interaction between cytomegalovirus and SARS-CoV-2 infection? Paul Moss
44 [GO] 2020―Mai―21 The lethal sex gap: COVID-19 Eladio J. Márquez, Jennifer Trowbridge, George A. Kuchel, Jacques Banchereau, Duygu Ucar
45 [GO] 2020―Apr―11 Can an effective SARS-CoV-2 vaccine be developed for the older population? Graham Pawelec, Nan-ping Weng
 [1] 

45 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec